RBE of 25 kV X-rays for the survival and induction of micronuclei in the human mammary epithelial cell line MCF-12A

Radiat Environ Biophys. 2006 Nov;45(4):253-60. doi: 10.1007/s00411-006-0062-3. Epub 2006 Sep 8.

Abstract

The broad application of low energy X-rays below about 50 keV in radiation therapy and diagnostics and especially in mammography substantiates the precise determination of their relative biological effectiveness (RBE). A quality factor of 1 is stated for photons of all energies in the International Commission on Radiological Protection Recommendations. However, the RBE of low-energy X-rays compared to high-energy photons was found to be dependent on photon energy, cell line and endpoints studied, hence varying from less than one up to about four. In the present study, the human mammary epithelial cell line MCF-12A has been chosen due to the implementation of the results in the estimation of risk from mammography procedures. The RBE of 25 kV X-rays (W anode, 0.3 mm Al filter) relative to 200 kV X-rays (W anode, 0.5 mm Cu filter) was determined for clonogenic survival in the dose range 1-10 Gy and micronuclei (MN) induction in the range 0.5-3.5 Gy. The RBE for clonogenic survival was found to be significantly higher than 1 for surviving fractions in the range 0.005<S<0.2. The RBE decreased with increasing survival, with an RBE0.1 at 10% survival of 1.13+/-0.03. The effectiveness of soft X-rays for MN induction was found to be 1.40+/-0.07 for the fraction of binuclear cells (BNC) with MN and 1.44+/-0.17 for the number of MN per BNC. In contrast, the RBE determined from the number of MN per MN-bearing BNC was found to be 1.08+/-0.32. This indicates that the effectiveness of 25 kV X-rays results from an increase in the number of damaged cells, which, however, do not have higher number of MN per cell.

Publication types

  • Comparative Study

MeSH terms

  • Cell Line
  • Cell Survival / radiation effects*
  • Dose-Response Relationship, Radiation
  • Epithelial Cells / radiation effects*
  • Female
  • Humans
  • Mammary Glands, Human / cytology*
  • Mammography / adverse effects
  • Mammography / methods*
  • Micronucleus Tests
  • Radiometry
  • Radiotherapy / adverse effects
  • Radiotherapy / methods*
  • Risk Assessment
  • X-Rays*